Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



IBERE PHARMACEUTICALS Create: Alert

All | News | Filings
Date FiledTypeDescription
03/13/2023 15-12G Form 15-12G - Securities registration termination [Section 12(g)]:
03/02/2023 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
02/14/2023 SC 13G GLAZER CAPITAL, LLC reports a 9.6% stake in Ibere Pharmaceuticals
02/14/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/08/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/08/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/02/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
08/12/2022 10-Q Quarterly Report for the period ended June 30, 2022
05/16/2022 10-Q Quarterly Report for the period ended March 31, 2022
03/31/2022 10-K Annual Report for the period ended December 31, 2021
02/14/2022 SC 13G/A CITADEL ADVISORS LLC reports a 5.6% stake in Ibere Pharmaceuticals
02/08/2022 SC 13G PIPV Capital LLC reports a 20% stake in Ibere Pharmaceuticals
01/14/2022 SC 13G Magnetar Financial LLC reports a 5.8% stake in IBERE PHARMACEUTICALS
11/12/2021 10-Q Quarterly Report for the period ended September 30, 2021
09/27/2021 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
08/16/2021 10-Q Quarterly Report for the period ended June 30, 2021
08/16/2021 10-Q/A Quarterly Report for the period ended March 31, 2021 [amend]
08/16/2021 8-K/A Quarterly results
08/13/2021 8-K Quarterly results
08/04/2021 8-K Quarterly results
07/16/2021 10-Q Quarterly Report for the period ended March 31, 2021
05/28/2021 8-K Quarterly results
05/18/2021 NT 10-Q Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
03/12/2021 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
03/08/2021 8-K Quarterly results
03/03/2021 8-K Quarterly results
03/02/2021 4 Vollmer Louis J. (Director) has filed a Form 4 on IBERE PHARMACEUTICALS
Txns: Bought 10,000 units @ $10, valued at $100k
03/01/2021 424B4 Form 424B4 - Prospectus [Rule 424(b)(4)]:
02/25/2021 3 Kerekes Zoltan (COO) has filed a Form 3 on IBERE PHARMACEUTICALS
02/25/2021 3 PIPV Capital LLC (10% Owner) has filed a Form 3 on IBERE PHARMACEUTICALS
02/25/2021 3 IMASOGIE OSAGIE O (CEO) has filed a Form 3 on IBERE PHARMACEUTICALS
02/25/2021 3 Vollmer Louis J. (Director) has filed a Form 3 on IBERE PHARMACEUTICALS
02/25/2021 3 Gray Lisa M. (CFO) has filed a Form 3 on IBERE PHARMACEUTICALS
02/25/2021 3 UKWU HENRIETTA (Director) has filed a Form 3 on IBERE PHARMACEUTICALS
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy